In the current month, AARD has received 3 Buy Ratings, 4 Hold Ratings, and 2 Sell Ratings. AARD average Analyst price target in the last month is 10.445.
Based on analysts' estimates, AARD EPS is projected to reach -0.695 in FY2026Q4, following reported EPS of -0.877 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.88, while Aardvark Therapeutics IncAARD's earnings per share (EPS) for the previous quarter was USD -0.66. EPS for the next quarter is expected at USD -0.69.